| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/1992 | EP0493985A1 Wound healing compositions containing fibroblast growth factor and ascorbic acid |
| 07/08/1992 | EP0493883A1 Cyclic (hetero)acetals of nitro substituted benzaldehydes having anti-cancer activity |
| 07/08/1992 | EP0493861A2 Antidepressive composition containing nicotinamid-adenin-dinucleotide |
| 07/08/1992 | EP0493782A2 Novel dihydropyridine amides, process for their preparation and drugs containing them |
| 07/08/1992 | EP0493770A2 Antiherpes compositions |
| 07/08/1992 | EP0493767A2 Synergistic combination for treating herpes infections |
| 07/08/1992 | EP0493761A1 Free-flowing and dust-free granular anabolic salinomycin biomass having unrestricted bioavailability of active agent and process for its production |
| 07/08/1992 | EP0493722A1 2-Halogeno-oxetanocin A and phosphoric ester thereof |
| 07/08/1992 | EP0493687A2 Treatment of sleep disorders using certain anti-depressants, e.g. nefazodone |
| 07/08/1992 | EP0493682A2 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans |
| 07/08/1992 | EP0493677A2 Solution for the reattachment of a detached retina to the choroid |
| 07/08/1992 | EP0493608A1 Quinolonecarboxylic acid derivative |
| 07/08/1992 | EP0493539A1 Synthetic conjugated bile acid and method of use thereof |
| 07/08/1992 | EP0493533A1 Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
| 07/08/1992 | EP0493496A1 Ibuprofen triturates and topical compositions containing same |
| 07/08/1992 | EP0493485A1 Erection-inducing methods and compositions |
| 07/08/1992 | EP0493444A1 Blood-brain barrier model |
| 07/08/1992 | EP0493404A1 Topical antiinflammatory compositions with minimal systemic absorption |
| 07/08/1992 | EP0493380A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs. |
| 07/08/1992 | EP0485486A4 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
| 07/08/1992 | EP0478702A4 Encapsulation process |
| 07/08/1992 | EP0344235B1 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/08/1992 | EP0309519B1 Pharmaceutical compositions containing pentamidine |
| 07/08/1992 | EP0202282B1 New use of 1,4-dihydropyridine derivatives |
| 07/08/1992 | CN1062537A Heparin derivatives |
| 07/08/1992 | CN1062536A Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 07/08/1992 | CN1062535A Derivatives of 10, 11, 12, 13-tetrahydrodesmycosin, processes for preparation, and use thereof in pharmaceuticals |
| 07/08/1992 | CN1062534A Methylenebisphosphonic acid derivatives |
| 07/08/1992 | CN1062533A Methylenebisphosphonic acid derivatives |
| 07/08/1992 | CN1062532A Methylenebisphosphonic acid derivatives |
| 07/08/1992 | CN1062529A Indole derivatives |
| 07/08/1992 | CN1062528A Benzodiazepinone |
| 07/08/1992 | CN1062526A Alkylaminoalkylamine and etherifying compounds and process for preparing same and intermediates and pharmaceuticals containing same |
| 07/08/1992 | CN1062525A Phenylalkylamino compounds and process for preparing same and pharmaceuticals containing same |
| 07/08/1992 | CN1062465A Progestagen-only contraceptive |
| 07/08/1992 | CN1062464A Contraceptive regimen |
| 07/08/1992 | CN1062463A Anticalculus oral composition |
| 07/08/1992 | CN1017338B Improved process for preparation of therapeutically useful, crosslinked dextran grain polymers |
| 07/08/1992 | CN1017336B Method of producing cephem compounds |
| 07/08/1992 | CA2099558A1 Pyrimido-benzothiazines |
| 07/07/1992 | USRE33988 Dietary supplementation with essential metal picolinates |
| 07/07/1992 | US5128493 Platinum complexes |
| 07/07/1992 | US5128479 Oxidized diphenylheteroalkanes |
| 07/07/1992 | US5128477 Famotidine |
| 07/07/1992 | US5128470 Aromatic carboxamides |
| 07/07/1992 | US5128458 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
| 07/07/1992 | US5128375 Keloid treating agent |
| 07/07/1992 | US5128374 Use of calcium citrate malate for the treatment of osteoporosis and related disorders |
| 07/07/1992 | US5128373 Storage stability |
| 07/07/1992 | US5128369 Arylalkylamine derivatives |
| 07/07/1992 | US5128367 Osteoporosis |
| 07/07/1992 | US5128366 Pyrrole derivatives |
| 07/07/1992 | US5128361 Imidazoline derivatives for systemic combating of ectoparasites in host animals |
| 07/07/1992 | US5128360 Method and agents for inhibiting protein aging |
| 07/07/1992 | US5128356 Angiotensin antagonist; cardiovascular disorders |
| 07/07/1992 | US5128354 3-sulfamoylmethyl-1,2-benzisooxazole |
| 07/07/1992 | US5128353 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
| 07/07/1992 | US5128352 Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides |
| 07/07/1992 | US5128351 Bis-aryl amide and urea antagonists of platelet activating factor |
| 07/07/1992 | US5128349 Vasodilators; cardiovascular disorders |
| 07/07/1992 | US5128347 Glycosidase inhibiting 1,4-dideoxy-4-fluoronojirimycin |
| 07/07/1992 | US5128345 Carcinostatic composition comprising indolquinolines |
| 07/07/1992 | US5128344 Sampangine and derivatives useful as an antifungal agent |
| 07/07/1992 | US5128343 Derivatives of pyrimidinyl-piperazinyl-alkyl azoles with anxiolytic and/or tranquilizing activity |
| 07/07/1992 | US5128341 Use of β-receptor blocking agents |
| 07/07/1992 | US5128340 Thiazole derivatives |
| 07/07/1992 | US5128338 Cardiovascular disorders |
| 07/07/1992 | US5128337 Lactamimides as calcium antagonists |
| 07/07/1992 | US5128335 Antibiotics |
| 07/07/1992 | US5128334 Analgesic and anti-inflammatory medicine |
| 07/07/1992 | US5128332 Method of treating cardiovascular diseases using inositoltrisphosphate |
| 07/07/1992 | US5128331 Gen-diphosphonates |
| 07/07/1992 | US5128327 Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle |
| 07/07/1992 | US5128325 Composition comprising monosodium glutamate for use in relieving fatigue |
| 07/07/1992 | US5128324 Transdermally applicable pharmaceutical preparations with sterolines and/or spiroketalines |
| 07/07/1992 | US5128323 Lactulose-free |
| 07/07/1992 | US5128318 High density lipoprotein, anticholesterol |
| 07/07/1992 | US5128249 Stable sulpho-adenosyl-l-methionine (same) salts, particularly suitable for oral pharmaceutical use |
| 07/07/1992 | US5128152 Iron-containing compositions and method for treating cancer |
| 07/07/1992 | US5128151 Stabilized menadione bisulfite formulations and their preparation |
| 07/07/1992 | US5128141 Otorhinolaryngological disorders |
| 07/07/1992 | US5128140 Gastrointestinal disorders; salt of bismuth, organic acid and an H2 receptor blocking anti-secretory agent |
| 07/07/1992 | US5128138 Estradiol compositions and methods for topical application |
| 07/07/1992 | US5128124 Administration of norethistereone-17-acetate |
| 07/07/1992 | US5128122 Nitrogen compound |
| 07/07/1992 | CA1304753C Iodonium ylide antimicrobial compounds |
| 07/07/1992 | CA1304741C Heterocyclic compounds |
| 07/07/1992 | CA1304740C Quaternary ammonium retinoates, their use as cosmetics and as dermotherapic medecine |
| 07/07/1992 | CA1304738C 7-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo- quinoline-3-carboxylic acids, processes for their preparation and antibacterial agents containing these compounds |
| 07/07/1992 | CA1304688C Fluid therapy with 1-lactate and/or pyruvate anions |
| 07/07/1992 | CA1304687C Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage |
| 07/07/1992 | CA1304686C Pharmaceutical composition containing cimetidine |
| 07/07/1992 | CA1304685C Pharmaceutical composition containing cimetidine |
| 07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
| 07/05/1992 | CA2058641A1 Dihydropyridine amides, processes for their preparation, and their use in medicaments |
| 07/05/1992 | CA2058198A1 Azole derivatives, process for their preparation, and their use |
| 07/04/1992 | WO1992012152A1 Process and intermediates for preparing azabicyclo[2.2.2]octan-3-imines |
| 07/04/1992 | WO1992011852A1 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis b |
| 07/04/1992 | CA2254613A1 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis b |
| 07/03/1992 | WO1992012142A1 2-imino 6-polyfluoralkyl 3-heterocyclylalkyl benzothiazoline derivatives, their preparation and drugs containing same |